Two Sigma Advisers
INO icon

Two Sigma Advisers’s Inovio Pharmaceuticals INO Stock Holding History

Two Sigma Advisers’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-73,701
Closed -$128K – 1045
2025
Q4 		$128K Sell
73,701
-35,000
-32% -$77.1K ﹤0.01% 2187
2025
Q3 		$254K Buy
+108,701
New +$208K ﹤0.01% 2055
2024
Q1 		– Sell
-9,775
Closed -$59.8K – 2537
2023
Q4 		$59.8K Buy
9,775
+8,675
+789% +$42.8K ﹤0.01% 2384
2023
Q3 		$5.13K Sell
1,100
-38,633
-97% -$213K ﹤0.01% 2354
2023
Q2 		$213K Buy
39,733
+38,016
+2,214% +$306K ﹤0.01% 2084
2023
Q1 		$16.9K Sell
1,717
-107,550
-98% -$1.83M ﹤0.01% 2528
2022
Q4 		$2.05M Sell
109,267
-79,183
-42% -$1.79M 0.01% 1233
2022
Q3 		$3.9M Sell
188,450
-64,108
-25% -$1.64M 0.01% 863
2022
Q2 		$5.24M Buy
252,558
+238,391
+1,683% +$6.72M 0.01% 753
2022
Q1 		$610K Buy
+14,167
New +$638K ﹤0.01% 1888
2020
Q2 		– Sell
-5,742
Closed -$513K – 2543
2020
Q1 		$513K Buy
5,742
+1,742
+44% +$107K ﹤0.01% 1797
2019
Q4 		$158K Buy
4,000
+1,058
+36% +$31.8K ﹤0.01% 2221
2019
Q3 		$72K Buy
2,942
+1,354
+85% +$41.2K ﹤0.01% 2134
2019
Q2 		$56K Buy
+1,588
New +$63.1K ﹤0.01% 2246
2018
Q4 		– Sell
-883
Closed -$59K – 2402
2018
Q3 		$59K Buy
+883
New +$49.2K ﹤0.01% 2171

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers's INO Position: Q1 2026 in Review

Two Sigma Advisers sold out of Inovio Pharmaceuticals (INO) in Q1 2026, closing a stake of 73,701 shares — an estimated $128K sold.

Two Sigma Advisers first reported a position in INO in Q3 2018 and held it in 15 quarters. The position peaked at $5.24M in Q2 2022. 100 funds tracked by Wall St. Rank hold INO as of Q1 2026.

  • Two Sigma Advisers reported no remaining Inovio Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 73,701 Inovio Pharmaceuticals shares in Q1 2026, an estimated $128K.
  • Two Sigma Advisers first reported a position in Inovio Pharmaceuticals in Q3 2018 and held it in 15 quarters.
  • Two Sigma Advisers's Inovio Pharmaceuticals position peaked at $5.24M in Q2 2022.
  • 100 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.